| Eli Lilly (Suisse) SA - Omvoh 100 mg + 200 mg, solution injectable en stylo prérempli | | 68952 | | 02 | | Omvoh 100 mg + 200 mg | | solution injectable en stylo prérempli | | L04AC | | Interleukin Inhibitors | | 20.06.2025 | | |
| | Composition | | II) 200 mg: mirikizumabum 200 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 2.2974 mg.
I) 100 mg: mirikizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.1487 mg. | | Packungsbestandteile | | II | | Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Mirikizumabum | 200mg / 2ml |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Mannitol | | Sodium Chloride | | Polysorbatum 80 |
|
| I | | Injection solution in prefilled syringe | | | | | | Active Agent | Dose |
|---|
| Mirikizumabum | 100 mg/ml |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Mannitol | | Sodium Chloride | | Polysorbatum 80 |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 1 + | PR | PR | B | | No |
|
|
